279 related articles for article (PubMed ID: 19779128)
1. Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility.
Cygalova LH; Hofman J; Ceckova M; Staud F
J Pharmacol Exp Ther; 2009 Dec; 331(3):1118-25. PubMed ID: 19779128
[TBL] [Abstract][Full Text] [Related]
2. Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line.
Staud F; Vackova Z; Pospechova K; Pavek P; Ceckova M; Libra A; Cygalova L; Nachtigal P; Fendrich Z
J Pharmacol Exp Ther; 2006 Oct; 319(1):53-62. PubMed ID: 16809480
[TBL] [Abstract][Full Text] [Related]
3. Transport of glyburide by placental ABC transporters: implications in fetal drug exposure.
Gedeon C; Behravan J; Koren G; Piquette-Miller M
Placenta; 2006; 27(11-12):1096-102. PubMed ID: 16460798
[TBL] [Abstract][Full Text] [Related]
4. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta.
Pollex E; Lubetsky A; Koren G
Placenta; 2008 Aug; 29(8):743-7. PubMed ID: 18558430
[TBL] [Abstract][Full Text] [Related]
5. Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta.
Neumanova Z; Cerveny L; Ceckova M; Staud F
AIDS; 2014 Jan; 28(1):9-17. PubMed ID: 24413260
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study.
Feinshtein V; Erez O; Ben-Zvi Z; Eshkoli T; Sheizaf B; Sheiner E; Holcberg G
Am J Obstet Gynecol; 2013 Dec; 209(6):573.e1-573.e15. PubMed ID: 23933222
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta.
Gedeon C; Anger G; Piquette-Miller M; Koren G
Placenta; 2008 Jan; 29(1):39-43. PubMed ID: 17923155
[TBL] [Abstract][Full Text] [Related]
8. Effect of oxygen on multidrug resistance in term human placenta.
Javam M; Audette MC; Iqbal M; Bloise E; Gibb W; Matthews SG
Placenta; 2014 May; 35(5):324-30. PubMed ID: 24685282
[TBL] [Abstract][Full Text] [Related]
9. Role of ABC and Solute Carrier Transporters in the Placental Transport of Lamivudine.
Ceckova M; Reznicek J; Ptackova Z; Cerveny L; Müller F; Kacerovsky M; Fromm MF; Glazier JD; Staud F
Antimicrob Agents Chemother; 2016 Sep; 60(9):5563-72. PubMed ID: 27401571
[TBL] [Abstract][Full Text] [Related]
10. ATP binding cassette transporters in two distinct compartments of the skin contribute to transdermal absorption of a typical substrate.
Hashimoto N; Nakamichi N; Uwafuji S; Yoshida K; Sugiura T; Tsuji A; Kato Y
J Control Release; 2013 Jan; 165(1):54-61. PubMed ID: 23089896
[TBL] [Abstract][Full Text] [Related]
11. Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs).
Hofman J; Kučera R; Neumanova Z; Klimes J; Ceckova M; Staud F
Xenobiotica; 2016; 46(5):416-23. PubMed ID: 26364927
[TBL] [Abstract][Full Text] [Related]
12. Characterization of efflux transporters involved in distribution and disposition of apixaban.
Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
[TBL] [Abstract][Full Text] [Related]
13. Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments.
Vaidya SS; Walsh SW; Gerk PM
Mol Pharm; 2009; 6(6):1689-702. PubMed ID: 19397308
[TBL] [Abstract][Full Text] [Related]
14. Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporin A.
Ejendal KF; Hrycyna CA
Mol Pharmacol; 2005 Mar; 67(3):902-11. PubMed ID: 15598974
[TBL] [Abstract][Full Text] [Related]
15. Etravirine inhibits ABCG2 drug transporter and affects transplacental passage of tenofovir disoproxil fumarate.
Reznicek J; Ceckova M; Tupova L; Staud F
Placenta; 2016 Nov; 47():124-129. PubMed ID: 27780535
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030
[TBL] [Abstract][Full Text] [Related]
17. [Expression and regulation of drug transporters in placenta].
Bai MR; Sun DL; Jiang HD; Zheng CH
Yao Xue Xue Bao; 2016 Jun; 51(6):879-85. PubMed ID: 29878741
[TBL] [Abstract][Full Text] [Related]
18. Transplacental transfer of nitrosodimethylamine in perfused human placenta.
Annola K; Heikkinen AT; Partanen H; Woodhouse H; Segerbäck D; Vähäkangas K
Placenta; 2009 Mar; 30(3):277-83. PubMed ID: 19215982
[TBL] [Abstract][Full Text] [Related]
19. Effect of oxygen on multidrug resistance in the first trimester human placenta.
Lye P; Bloise E; Dunk C; Javam M; Gibb W; Lye SJ; Matthews SG
Placenta; 2013 Sep; 34(9):817-23. PubMed ID: 23790363
[TBL] [Abstract][Full Text] [Related]
20. Substrate- and species-dependent inhibition of P-glycoprotein-mediated transport: implications for predicting in vivo drug interactions.
Zolnerciks JK; Booth-Genthe CL; Gupta A; Harris J; Unadkat JD
J Pharm Sci; 2011 Aug; 100(8):3055-3061. PubMed ID: 21484807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
